All News

    FDA Approves Welireg for Pheochromocytoma and Paraganglioma

    May 14th 2025, 5:02pm

    Article

    The FDA approved Welireg for adult and pediatric patients 12 and older with locally advanced, unresectable or metastatic pheochromocytoma or paraganglioma.

    Aidixi Combination Therapy Improves Survival in Urothelial Carcinoma

    May 14th 2025, 3:00pm

    Article

    Aidixi plus toripalimab met progression-free and overall survival study end points versus chemo for patients with HER2-expressing urothelial carcinoma.

    Bone Metastasis Count May Guide Erleada Treatment in Prostate Cancer

    May 14th 2025, 1:00pm

    Article

    The addition of Erleada to ADT may provide less benefit in patients with metastatic castration-sensitive prostate cancer and fewer bone metastases.

    My Rare Cancer Gave Me Permission to Live

    May 13th 2025, 9:00pm

    Article

    After walking alone in Chicago’s Cancer Survivor’s Walk, I found strength, healing and a renewed commitment to live fully and authentically — starting now.

    Why Relationships are Key When Caring For Patients With MPNs

    May 13th 2025, 8:00pm

    Video

    Building long-term trust with providers can help patients with MPNs feel supported, encourage them to speak up and navigate care with confidence.

    Understanding the Unique Task of Treating Older Patients With Breast Cancer

    May 13th 2025, 7:00pm

    Article

    Dr. Hyman B. Muss discusses the unique challenges that older patients with breast cancer face during and after treatment for their disease.

    I Found Strength After Surviving Multiple Myeloma and Through Recovery

    May 13th 2025, 5:00pm

    Article

    I share how I survived multiple myeloma, painful spine fractures and years of recovery to reclaim my independence and vitality.

    Custom-Made Vaccine Combo Proves Effective in Bladder Cancer

    May 13th 2025, 4:00pm

    Article

    Treatment with a custom-made vaccine combination was found to be safe and feasible for patients with bladder cancer, eliciting a strong immune response.

    Perjeta Regimen Improves Survival in HER2+ Early-Stage Breast Cancer

    May 13th 2025, 3:00pm

    Article

    Treatment with Perjeta, Herceptin and chemotherapy post-surgery led to a significant overall survival benefit in HER2-positive early-stage breast cancer.

    Cracked, Not Broken: Life After Breast Cancer

    May 13th 2025, 1:00pm

    Article

    Breast cancer cracked me open but didn’t break me — it gave me voice, purpose and courage to dream boldly, live fully and speak up for those who can’t.